U.S. Hotel and Resort REITs Stock News

On August 14, 2025, Antero Resources Corporation and Antero Midstream Corporation announced a leadership transition, with Michael N. Kennedy promoted to Chief Executive Officer and President, and Co-Founder Paul M. Rady moving to Chairman Emeritus; Brendan E. Krueger was named Chief Financial Officer, and the roles of Chairman of the Board and CEO were separated, with Benjamin A. Hardesty appointed as Chairman of Antero Resources. This shift marks a significant update to Antero's executive...

On August 20, 2025, Stock Yards Bancorp, Inc. announced its board of directors raised the quarterly cash dividend to $0.32 per common share, payable October 1, 2025, to shareholders of record as of September 15, 2025. This dividend increase reflects management’s conviction in the company’s underlying financial strength and can enhance its appeal to income-focused investors. We'll examine how the dividend hike underscores Stock Yards Bancorp’s commitment to shareholder returns and shapes its...

Scorpio Tankers recently announced its second-quarter 2025 results, reporting both revenue and earnings above analyst expectations, and declared a US$0.40 quarterly cash dividend per share. The company’s focus on maintaining a young, efficient fleet and a robust balance sheet was highlighted as key to its current performance and positive outlook. We’ll explore how Scorpio’s strong financial results and ongoing shareholder returns shape the investment narrative for the company going...

NCR Voyix Corporation recently announced its second quarter 2025 earnings, reporting revenue of US$666 million versus US$722 million a year earlier and a narrowed quarterly loss, while maintaining its full-year revenue guidance of US$1.995 billion to US$2.02 billion. Despite a year-over-year revenue decline, the company reduced its net losses and reaffirmed its outlook, signaling potential progress in operational efficiency during a period of continued business transformation. We'll examine...

Are you wondering whether now is the right time to jump into Centene stock, or if it is better to sit tight given the recent market noise? Investors have been eyeing CNC shares closely as the healthcare sector continues to ride out policy changes and market shifts. Over the past month, Centene’s share price has climbed more than 7%, shrugging off a rocky 90-day stretch where the stock fell nearly 5%. It is a resilient showing, especially considering the year-to-date returns are still down...

Avidity Biosciences recently reported its second quarter 2025 earnings, revealing a net loss of US$157.32 million and basic loss per share from continuing operations of US$1.21, both higher than for the same period last year. Avidity also entered into a multi-year manufacturing agreement with Lonza, committing to purchase approximately US$620 million in drug products between 2026 and 2028 to support future commercial plans. We'll explore how Avidity's major manufacturing commitment with...

Dover (DOV) caught the attention of investors this week after its shares slipped another 0.5% in a single day, extending a downtrend that has been unfolding quietly but steadily over the past month. There was no headline-grabbing event behind this latest move. The drop appears to be a continuation of the market’s current lukewarm view on the stock rather than a direct reaction to fresh news. Still, Dover’s wide reach across industrial markets means that even drifting price action can reflect...

If you are eyeing Palantir Technologies stock and wondering whether to hold, buy more, or maybe even cash out, you are not alone. This is a stock that has captured headlines, fan enthusiasm, and a fair dose of debate over its true worth. Over just the past three months, Palantir has delivered a 27.6% gain. At the one-year mark, that return increases to a notable 379%. Those numbers have many investors wondering if there is still more room to run or if the good news is already priced...

In recent days, J.P. Morgan analyst Bryan Smilek maintained a Hold rating on Etsy, citing the impact of the global suspension of the de minimis trade exemption and ongoing macroeconomic pressures influencing the company's growth prospects. The change in trade policy is expected to raise prices across the e-commerce industry, which could offer U.S.-focused platforms like Etsy a competitive edge over Asia-based rivals. We'll explore how the suspension of the de minimis exemption and shifting...

DigiCert recently announced its participation in a National Institute of Standards and Technology (NIST) National Cybersecurity Center of Excellence (NCCoE) project, joining 13 other leading technology firms, including CyberArk, to develop and demonstrate integrated solutions for secure software development, operations, and monitoring. This marks a rare industry-wide collaboration, showcasing CyberArk’s expertise alongside major peers in a U.S. government-sponsored effort to strengthen...

If you are thinking about what to do with Venture Global stock right now, you are definitely not alone. With so many energy names under the spotlight, this one stands out—whether you are considering getting in, staying put, or perhaps trimming your position. The recent moves in the stock have certainly caught the market’s attention. Just in the last quarter, the price jumped over 14%. While there have been short-term pullbacks, including a 7.9% dip in the past week, VG still has some...

Loma Negra Compañía Industrial Argentina Sociedad Anónima recently reported its second quarter and six-month 2025 financial results, revealing ARS174.51 billion in quarterly sales and ARS397 million in net income, both lower than the prior-year period. An interesting detail is the steep year-on-year decline in basic earnings per share, from over ARS350 to ARS3.40 for the quarter, underscoring significant earnings pressure faced by the company. We'll examine how these sharply lower earnings...

Regeneron Pharmaceuticals (REGN) investors received news this week that the U.S. Food and Drug Administration has pushed back the target decision dates for two crucial EYLEA HD regulatory submissions to late 2025. This extension could delay the timeline for potential new approvals, adding more uncertainty to a product line that is central to Regeneron’s future business plans. Although this might seem like just another regulatory hurdle, the stakes are significant for those watching the...

If you are eyeing Exelixis and wondering if now is the right moment to get in, you are not alone. Plenty of investors are weighing the same question, especially after seeing the company deliver a solid one-year total return of nearly 47% and an even more impressive three-year gain of over 100%. While there has been some recent turbulence, with a roughly 15% dip over the past month, Exelixis remains up by more than 11% year to date. That kind of performance does not go unnoticed, and it...

NasdaqGS:TTMI 1 Year Share Price vs Fair Value Explore TTM Technologies's Fair Values from the Community and select...

Targa Resources recently reported second-quarter results, including revenue of US$4.26 billion and net income of US$629.1 million, alongside confirmation of a share repurchase program up to US$1 billion and full-year 2025 net income guidance of US$1.83 billion. Management emphasized a focus on organic growth while remaining open to bolt-on acquisitions, and continued delivering higher NGL production and robust shareholder returns through stock buybacks. We'll explore how Targa Resources'...

As the United States market navigates a tech stock slump and anticipates insights from Federal Reserve Chair Jerome Powell, small-cap stocks may present unique opportunities amid broader market volatility. In this environment, identifying promising small-cap companies can be crucial for investors seeking diversification and potential growth, as these "undiscovered gems" often thrive by capitalizing on niche markets or innovative strategies.

Nu Holdings (NYSE:NU) has recently gained momentum, catching the eye of investors who follow international banking and fintech stocks. The company’s shares have climbed over 10% in the past week, building on a steady run that has outpaced many of its regional peers. This latest rally, coming without a headline-grabbing catalyst, raises an interesting question: is the market sensing an inflection point for the business, or is this simply a case of shifting sentiment toward high-growth...

SolarEdge Technologies (SEDG) is making waves this week after posting a steady double-digit climb over the past month, drawing new attention from investors wondering if momentum is building. While there hasn't been a major headline setting off this move, some are now looking for clues in the price action itself, speculating that shifting sentiment around clean energy stocks or the broader tech sector might be playing a role. The stock’s resilience could be signaling a change in expectations,...

On August 6, 2025, UGI Corporation amended its credit agreement to secure a new US$300 million senior secured revolving loan facility, enhancing its financial flexibility to address the conversion of its 2028 Notes and aligning with JPMorgan Chase Bank, N.A. as the administrative agent. This development signals UGI's proactive approach to managing upcoming debt obligations and reinforces its focus on liquidity and capital planning. We'll explore how securing this revolving loan facility...

Vertex Pharmaceuticals (VRTX) has seen its stock tick up by nearly 1% today, catching the attention of investors who are watching for signals in a sector driven by both innovation and changing sentiment. While there is no headline event or major news announcement behind this move, modest fluctuations like this can sometimes prompt investors to reassess their conviction, especially after a period of drifting prices. With no clear trigger in play, the question becomes whether this recent...

If you’re holding Marex Group (NasdaqGS:MRX) or considering an investment, the recent short report has likely caught your attention. Accusations regarding questionable off-balance sheet dealings and misleading disclosures have put Marex under scrutiny, raising challenging questions for investors about the reliability of its financial statements. With a shareholder rights law firm now investigating, an additional legal concern has emerged that is difficult to overlook. Marex has experienced...

Gilead Sciences recently reported improved quarterly revenues and net income, raised its full-year 2025 guidance, declared its third-quarter dividend, and authorized a US$6.0 billion share repurchase program; in addition, Erin Burkhart was appointed as Senior Vice President, Controllership and principal accounting officer, effective September 22, 2025. The combination of robust financial results, upward guidance revision, and a sizable new buyback program suggests a clear focus on capital...

On August 8, 2025, DigitalBridge Group reported second-quarter results showing negative revenue of US$3.21 million, a very large decline from the US$390.34 million reported a year earlier, and net income fell to US$31.62 million from US$91.42 million. This rare instance of negative revenue and lower profitability raises important questions about the company’s operational performance and the drivers behind such a shift year-over-year. We will explore how the company’s unexpected negative...